Skip to main content
Clinical Trials/JPRN-jRCT1032180086
JPRN-jRCT1032180086
Recruiting
Phase 2

Phase II trial of Proton Radiation Therapy for skull base chordoma and chondrosarcoma. - PRT for skull base chordoma and chondrosarcoma. (Pro-Chordo Study)

Sakurai Hideyuki0 sites60 target enrollmentJanuary 17, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Sakurai Hideyuki
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sakurai Hideyuki

Eligibility Criteria

Inclusion Criteria

  • 1, Pathological diagnosis is chordoma or chondrosarcoma
  • 2, General condition is maintained (PS 0\-2 or PS 3 caused by tumor)
  • 3, When tumor is controlled,5\-year survival is expected.
  • 4, Obtain written informed consent.
  • 5, 15 years old or more.

Exclusion Criteria

  • 1, Multiple primary cancers
  • 2, Invasion for brain stem or optic chiasm
  • 3, Distant metastases
  • 4, Active infectious meningitis
  • 5, Pregnant, unwilling to practice contraception during study, or lactating female.
  • 6, Not suitable for participation by mental illnesses
  • 7, Difficult to participate by the judgment of a doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials